The following is excerpted from an online article posted by ScienceDaily
A promising group of medications already used to treat diabetes and obesity may also hold potential for tackling alcohol and drug addiction, according to a new study published in the Journal of the Endocrine Society.
These drugs, called Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs), could represent a hopeful new direction for addressing alcohol and other substance use disorders.
Source: ScienceDaily
https://www.sciencedaily.com/releases/2025/10/251026021746.htm